Clinical Research Directory

Inclusion Criteria: 1. Subject has clinical indication to cardiac pacing in adherence with ESC cardiac pacing guidelines. 2. Subject is ≥ 18 years of age or age of legal consent, whichever age is greater. 3. Subject agrees to return to clinic for the study follow-up visits. 4. Subject has been informed of the nature of the study, agrees to its provisions and has provided a signed written informed consent, approved by IRB/EC. Exclusion Criteria: 1. Subject is currently participating in another study that may confound the results of this research. 2. Subject has a life expectancy less than 12 months. 3. Subject is pregnant or nursing or planning pregnancy during the study. 4. Subject has anatomic or comorbid conditions, or other medical, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the study or to comply with the site standard follow-up visits, for example a mechanical tricuspid \- Page 3 of 4 \[DRAFT\] - valve prosthesis or vein thrombosis, which could impede the delivery of implantable devices as planned by the implanters. 5. Subject is allergic/hypersensitive to \<1 mg dexamethasone sodium phosphate. 6. Subject is implanted with an electrically active implantable medical device with stimulation capabilities at risk to be impacted by the Aveir Link Module telemetry. 7. Subject has known pacemaker syndrome, if that condition, in the investigator's opinion, represents a contraindication to the implant of the planned pacemaker. 8. Subject has pacing induced cardiomyopathy.